Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take
Fierce Pharma
Fri, 04/21/23 - 10:22 am
Novo Nordisk
Eli Lilly
Sanofi
insulin
diabetes
drug prices
Novo’s latest deal targets cell therapy for diabetes, obesity
BioPharma Dive
Thu, 04/13/23 - 12:02 pm
Novo Nordisk
cell therapy
diabetes
obesity
Aspect Biosystems
Bernie Sanders weighs Senate hearing for largest insulin makers
Seeking Alpha
Thu, 04/13/23 - 11:53 am
Bernie Sanders
diabetes
insulin
drug pricing
Eli Lilly
Sanofi
Novo Nordisk
Senate
Abbott’s CGM Readers Face Class I Recall Over Lithium-ion Battery Issues
Medical Devices and Diagnostics Industry
Tue, 04/11/23 - 07:12 pm
Abbott Labs
device recalls
Medtech
diabetes
FreeStyle Libre
Abbott glucose monitor readers could catch fire, FDA warns in recall notice
Stat
Fri, 04/7/23 - 01:46 pm
Abbott Labs
Medtech
FDA
product recalls
diabetes
blood glucose monitoring
Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes
Xtalks
Fri, 04/7/23 - 01:43 pm
Eli Lilly
Mounjaro
DTC ads
television ads
diabetes
Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market
Motley Fool
Thu, 04/6/23 - 11:29 am
Novo Nordisk
diabetes
Ozempic
Rybelsus
Diabesity drugs and their free ‘contract sales force’
Medical Marketing and Media
Tue, 04/4/23 - 10:12 am
Novo Nordisk
Eli Lilly
diabetes
obesity
telehealth
social media
Mounjaro
Wegovy
Biomea goes for $125M offering after early diabetes data nearly doubled stock price
Endpoints
Wed, 03/29/23 - 10:05 am
Biomea Fusion
diabetes
clinical trials
Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality
Endpoints
Tue, 03/28/23 - 11:46 am
Vertex Pharmaceuticals
diabetes
CRISPR
gene editing
CRISPR Therapeutics
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Mon, 03/27/23 - 11:23 am
Novo Nordisk
Rybelsus
diabetes
clinical trials
Eli Lilly
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
Investors Business Daily
Sun, 03/26/23 - 11:28 pm
Novo Nordisk
Ozempic
diabetes
obesity
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Sun, 03/26/23 - 03:36 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
In insulin resistance pact, Dewpoint adds Novo Nordisk to its pharma-rich pipeline
Enpoints
Wed, 03/22/23 - 11:13 am
Dewpoint Therapeutics
Novo Nordisk
diabetes
insulin resistance
condensates
Six-month Ozempic shortage mostly over after weight-loss craze drained supply
Seattle Times, WA
Mon, 03/20/23 - 04:39 pm
Novo Nordisk
drug shortages
Ozempic
diabetes
weight loss
California takes another step forward in its insulin production with $50M investment
Endpoints
Mon, 03/20/23 - 04:37 pm
California
insulin
diabetes
Merck, Viatris agree to settle patent feud surrounding diabetes drugs
Endpoints
Mon, 03/20/23 - 04:30 pm
Merck
Viatris
patents
diabetes
Januvia
Janumet
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Endpoints
Thu, 03/16/23 - 09:16 pm
Sanofi
Lantus
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly
BioSpace
Wed, 03/15/23 - 10:06 am
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »